002262SZSE

Jiangsu En Hua Pharmaceutical Co., Ltd. 2025 Annual General Meeting Resolution Announcement

✨ AI Summary

This announcement details the resolutions passed at Jiangsu En Hua Pharmaceutical Co., Ltd.'s 2025 Annual General Meeting. Key decisions included approving the Board of Directors' work report, the annual report, the profit distribution plan, and the proposal for cash management. All proposals were approved by a significant majority of shareholders, including independent investors.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002262 Securities Abbreviation: En Hua Pharmaceutical Announcement Number: 2026-016

Jiangsu En Hua Pharmaceutical Co., Ltd. 2025 Annual General Meeting Resolution Announcement

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.

Special Notes:

  1. There were no proposals rejected at this general meeting.
  2. This general meeting does not involve any changes to resolutions previously passed.
  3. To respect the rights and interests of small and medium investors and increase their participation in major resolutions of the general meeting, separate vote counting was conducted for small and medium investors on resolutions at this general meeting.

I. Meeting Convening Situation

(I) Meeting Time On-site meeting time: 9:00 AM, Friday, May 15, 2026. Online voting time: The specific time for online voting through the Shenzhen Stock Exchange system is May 15, 2026, from 9:15-9:25, 9:30-11:30, and 13:00-15:00; the specific time for voting through the Shenzhen Stock Exchange internet voting system is any time from 9:15 to 15:00 on May 15, 2026.

(II) On-site Meeting Location: Meeting Room 301, 3rd Floor, En Hua Technology Building, No. 31 Longhu West Road, Xuzhou Economic and Technological Development Zone.

(III) Convenor: The Board of Directors of Jiangsu En Hua Pharmaceutical Co., Ltd.; Chairman: Mr. Sun Pengsheng.

(IV) Meeting Method: A combination of on-site voting and online voting.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.